Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (17)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Abrahamsen, A. F.
Right arrow Articles by Kvaløy, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abrahamsen, A. F.
Right arrow Articles by Kvaløy, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 7:145-150, 1996
© 1996 European Society for Medical Oncology


research-article

Clinical stage I and II Hodgkin's disease: Long-term results of therapy without laparotomy

Experience at one institution

A. Foss Abrahamsen1, E. Hannisdal1, O. Nome1, H. Holte1, B. Hager2, R Langholm3 and S. Kvaløy1

1Department of Medical Oncology and Radiotherapy Oslo, Norway
2Department of Diagnostic Radiology Oslo, Norway
3Department of Pathology, The Norwegian Radium Hospital Oslo, Norway

A. Foss Abrahamsen, M.D. The Norwegian Radium Hospital Montebello 0310 Oslo Norway

Background: We concluded a program in which we administered radiotherapy only to clinical stages I and II Hodgkin's disease patients at standard risk, with the addition of 4 cycles of combination chemotherapy before radiotherapy for high-risk patients.

Patients and methods: From 1980 to 1991, 313 patients with clinical stages I or II Hodgkin's disease underwent treatment in our hospital. Fifty percent of the patients in groups previously identified as being at high risk for relapse received 4 cycles of combination chemotherapy before radiotherapy. The remaining half of the patients received radiotherapy only.

Results: Low- and high-risk patients aged 15–59 years had, respectively, complete remission (CR) rates of 97% and 94%, 5-year survivals of 95% and 91%, and 5-year freedom from relapse (FFR) rates of 78% and 89%. Older low- and high-risk groups had CR rates of 97% and 93%, 5-year survivals of 60% and 56% and 5-year FFR of 77% and 93%, respectively.

Conclusion: Here we present our favorable results after treating standard-risk patients with clinical stages I and II Hodgkin's disease with radiotherapy only. With the addition of chemotherapy, the rate of relapse in the high-risk patients was reduced below that of the standard-risk patients. Overall survival was the same for the high- and standard-risk patients.

adjuvant chemotherapy, Hodgkin's disease, radiotherapy, stages I and II


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
JCOHome page
M. J. Hjermstad, S. D. Fossa, L. Oldervoll, H. Holte, A. B. Jacobsen, and J. H. Loge
Fatigue in Long-Term Hodgkin's Disease Survivors: A Follow-Up Study
J. Clin. Oncol., September 20, 2005; 23(27): 6587 - 6595.
[Abstract] [Full Text] [PDF]


Home page
Neuro Oncol DukeHome page
J. Biagi, R. G. MacKenzie, M. S. Lim, M. Sapp, and N. Berinstein
Primary Hodgkin's disease of the CNS in an immunocompetent patient: A case study and review of the literature
Neuro-oncol, October 1, 2000; 2(4): 239 - 243.
[Abstract] [PDF]


Home page
JCOHome page
A. Wirth, M. Chao, J. Corry, C. Laidlaw, K. Yuen, G. Ryan, D. Byram, S. Davis, J. Kiffer, G. Quong, et al.
Mantle Irradiation Alone for Clinical Stage I-II Hodgkin's Disease: Long-Term Follow-Up and Analysis of Prognostic Factors in 261 Patients
J. Clin. Oncol., January 1, 1999; 17(1): 230 - 230.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.